Abiopharma

🔍 Saunders Richard (Executive)

Company: Bank of N.T. Butterfield & Son Ltd (NTB)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 51 shares of Restricted Stock Units - EDIP (Derivative)
  Date: 2026-08-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,008.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F3
• Acquired 318 shares of Restricted Stock Units - ELTIP (Derivative)
  Date: 2026-08-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 37,773.00 | transaction_form_type: 4 | Footnotes: F1, F1, F4, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting/settlement.
• F2: The restricted stock units vest 10-Feb-2027, 12-Feb-2027, 10-Feb-2028 subject to continued service through each vesting date.
• F3: These restricted stock units do not expire; they either vest and settle or are forfeited/cancelled prior to the applicable vesting date.
• F4: The PSUs will vest on the third anniversary of the Grant Date 12-Feb-2027, 10-Feb-2028.